CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $339 | -99.9% | 79,264 | -13.5% | 0.00% | -100.0% |
| Q3 2022 | $515,000 | -17.5% | 91,639 | -26.5% | 0.00% | – |
| Q1 2022 | $624,000 | +376.3% | 124,682 | +137.4% | 0.00% | – |
| Q4 2021 | $131,000 | -1.5% | 52,519 | +15.8% | 0.00% | – |
| Q3 2021 | $133,000 | +30.4% | 45,353 | +10.9% | 0.00% | – |
| Q2 2021 | $102,000 | +5.2% | 40,900 | +12.4% | 0.00% | – |
| Q1 2021 | $97,000 | +223.3% | 36,400 | +3.7% | 0.00% | – |
| Q2 2019 | $30,000 | -3.2% | 35,100 | +9.3% | 0.00% | – |
| Q1 2019 | $31,000 | +138.5% | 32,100 | +96.9% | 0.00% | – |
| Q4 2018 | $13,000 | -78.0% | 16,300 | -40.3% | 0.00% | – |
| Q3 2018 | $59,000 | -59.3% | 27,322 | -26.4% | 0.00% | – |
| Q2 2018 | $145,000 | 0.0% | 37,104 | 0.0% | 0.00% | – |
| Q1 2018 | $145,000 | +291.9% | 37,104 | +222.6% | 0.00% | – |
| Q3 2017 | $37,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Legal & General Group Plc | 9,340 | $84,901 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 92,700 | $389,340 | 0.00% |
| FNY Investment Advisers, LLC | 20 | $0 | 0.00% |